4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Bronchial Spasm in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
Bronchial Spasm: Spasmodic contraction of the smooth muscle of the bronchi.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Rapacuronium, which sought to fulfill these criteria, was withdrawn from clinical use due to a high incidence of bronchospasm resulting in death." | 7.72 | A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. ( Emala, CW; Hirshman, CA; Jooste, E; Klafter, F, 2003) |
| " Rapacuronium, which sought to fulfill these criteria, was withdrawn from clinical use due to a high incidence of bronchospasm resulting in death." | 3.72 | A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. ( Emala, CW; Hirshman, CA; Jooste, E; Klafter, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jooste, E | 1 |
| Klafter, F | 1 |
| Hirshman, CA | 1 |
| Emala, CW | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Bronchial Spasm
| Article | Year |
|---|---|
A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
Topics: Animals; Atracurium; Binding, Competitive; Bronchial Spasm; Cell Membrane; CHO Cells; Cricetinae; Di | 2003 |